SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
饼饼
Lv6
2400 积分
2023-08-05 加入
最近求助
最近应助
互助留言
Efficacy and safety of eculizumab in aquaporin-4-antibody-positive neuromyelitis optica spectrum disorder: A phase 3, randomized, double-blind, placebo-controlled, multicenter trial (PREVENT)
11个月前
已关闭
Myasthenic crisis
1年前
已完结
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study
1年前
已完结
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial
1年前
已完结
Comparison on the effect of seven drugs to prevent relapses of neuromyelitis optica spectrum disorders: A modeling analysis of literature aggregate data
1年前
已完结
Anti-C5 Antibody Treatment Ameliorates Weakness in Experimentally Acquired Myasthenia Gravis
1年前
已完结
Efficacy and Safety of Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: Evidence from Randomized Controlled Trials
1年前
已完结
Comparison on the effect of seven drugs to prevent relapses of neuromyelitis optica spectrum disorders: A modeling analysis of literature aggregate data
1年前
已完结
Eculizumab treatment for myasthenia gravis subgroups: 2021 update
1年前
已完结
Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report
1年前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论